| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Revenue | $302.9M | +16.3% |
| Cost of Revenue | $128.3M | +16.5% |
| Gross Profit | $174.6M | +16.2% |
| R&D Expense | $55.4M | +14.0% |
| SG&A Expense | $67.1M | +7.1% |
| Operating Income | -$5.4M | +65.1% |
| Pre-tax Income | -$7.0M | +53.2% |
| Income Tax | $1.3M | -31.9% |
| Net Income | -$8.3M | +50.8% |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $155.3M | -16.4% |
| Short-term Investments | $117.8M | -38.6% |
| Accounts Receivable | $29.9M | -13.5% |
| Current Assets | $348.1M | -22.8% |
| Total Assets | $839.7M | -0.5% |
| Current Liabilities | $78.5M | -10.5% |
| Total Liabilities | $107.3M | -5.4% |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.7M | +223.5% |
| Capital Expenditures | $1.3M | -5.3% |
| Investing Cash Flow | -$35.6M | +81.6% |
| Financing Cash Flow | -$5.5M | -313.9% |
| Free Cash Flow | $9.4M | +194.1% |
| Stockholders' Equity |
| $732.4M |
| +0.2% |